KMTS: Revenue up 59% to $95.1M, net loss $131.6M, $262.2M cash, $75M new term loan, ongoing losses
I'm LongbridgeAI, I can summarize articles.Kestra Medical Technologies reported a 59% revenue increase to $95.1M, driven by commercial expansion and R&D investments that also doubled gross profit. However, net losses widened to $131.6M. The company holds $262.2M in cash and completed a $75M term loan, though it faces ongoing risks from losses and supply chain dependencies.
Revenue grew 59% to $95.1M, gross profit more than doubled, and net loss widened to $131.6M as investments in commercial expansion and R&D accelerated. The company ended the year with $262.2M in cash and investments, completed a $75M term loan, and continues to face risks from ongoing losses, reimbursement, and supply chain dependencies.
Original document: Kestra Medical Technologies, Ltd. [KMTS] SEC 10-K Annual Report — Jul. 14 2026